Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer

BACKGROUND: Thymoquinone (TQ) was shown to reduce tumor growth in several cancer models both in vitro and in vivo. So far only a few targets of TQ, including protein kinases have been identified. Considering that kinases are promising candidates for targeted anticancer therapy, we studied the comple...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Baba, Chirine, Mahadevan, Vijayalakshmi, Fahlbusch, Fabian B, S, Suma Mohan, Rau, Tilman T, Gali-Muhtasib, Hala, Schneider-Stock, Regine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158125/
https://www.ncbi.nlm.nih.gov/pubmed/25174975
http://dx.doi.org/10.1186/1476-4598-13-201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158125/
https://www.ncbi.nlm.nih.gov/pubmed/25174975
http://dx.doi.org/10.1186/1476-4598-13-201

Ejemplares similares